Raymond James & Associates’s Molecular Data Inc. American Depositary Shares MKD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-4,733
Closed -$77K 4267
2021
Q1
$77K Buy
+4,733
New +$88.4K ﹤0.01% 3809

Other funds holding MKD

Raymond James & Associates's MKD Position: Q2 2021 in Review

Raymond James & Associates sold out of Molecular Data Inc. American Depositary Shares (MKD) in Q2 2021, closing a stake of 4,733 shares — an estimated $77K sold.

Raymond James & Associates first reported a position in MKD in Q1 2021 and held it in 1 quarter. The position peaked at $77K in Q1 2021. 8 funds tracked by Wall St. Rank hold MKD as of Q2 2021.

  • Raymond James & Associates reported no remaining Molecular Data Inc. American Depositary Shares position as of Q2 2021 after selling out during the quarter.
  • Raymond James & Associates sold 4,733 Molecular Data Inc. American Depositary Shares shares in Q2 2021, an estimated $77K.
  • Raymond James & Associates first reported a position in Molecular Data Inc. American Depositary Shares in Q1 2021 and held it in 1 quarter.
  • Raymond James & Associates's Molecular Data Inc. American Depositary Shares position peaked at $77K in Q1 2021.
  • 8 funds tracked by Wall St. Rank held Molecular Data Inc. American Depositary Shares as of Q2 2021.

Based on Raymond James & Associates's 13F filing for Q2 2021, filed 11 Aug 2021.